Purchase Order SPE2DP26P0043
- Not listed
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a $2,990.79 firm fixed-price delivery order to Sanofi Pasteur Inc. for influenza virus vaccine on April 15, 2025. The contract, with an ultimate completion date of April 18, 2025, does not utilize any set-aside designation. Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer headquartered in Swiftwater, Pennsylvania, is a critical supplier of vaccines and medical countermeasures to multiple federal...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines and medical supplies. The contract, valued at $1,336,273.60, is for the delivery of influenza virus vaccines. The contract has an ultimate completion date of September 26, 2025 and does not have a set-aside designation. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical...
- This is a $6,025,705.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of influenza virus vaccines. The contract has an ultimate completion date of September 26, 2025 and does not utilize any set-aside designations. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical countermeasures to various U.S. federal government agencies,...
- This firm fixed price purchase order was awarded to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer of pharmaceutical products, to provide influenza virus vaccines to the Medical Supply Chain, a component of the Defense Logistics Agency. The $1,548.18 contract has a completion date of September 30, 2024 and is not associated with any set-aside designation. Sanofi Pasteur Inc. is an experienced federal contractor, holding several Indefinite Delivery Vehicles (IDVs) with the...
- This is a firm fixed price purchase order awarded by the Defense Logistics Agency Troop Support Medical to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer of vaccines and pharmaceuticals. The $100,810 contract is for the provision of influenza virus vaccine, with a completion date of September 15, 2020. The award does not have a set-aside designation. Sanofi Pasteur Inc. is a major supplier of vaccines, pharmaceuticals, and medical supplies to various U.S. government agencies,...
- This is a delivery order contract awarded by the Medical Supply Chain, a component of the Defense Department, to Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer of vaccines and medical supplies. The contract is for the delivery of influenza virus vaccines, with a ceiling value of $804,900.80 and a period of performance ending on September 26, 2025. The contract is a firm fixed price vehicle and does not utilize any set-aside designations. Sanofi Pasteur Inc. is a major...
- This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer of vaccines and medical supplies, for the provision of influenza virus vaccines. The contract has a ceiling value of $983,915.20 and is a firm fixed price delivery order, with an ultimate completion date of September 26, 2025. The contract is awarded by the Defense Logistics Agency, a component of the Department of Defense, and is not set aside for any specific business category....
- This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the production of influenza virus vaccines. The contract, awarded by the Medical Supply Chain division of the Defense agency, is a delivery order with a firm fixed price of $3,150,107.50 and an ultimate completion date of October 13, 2023. The contract does not have a set-aside designation. Sanofi Pasteur Inc. is a major supplier of vaccines and medical countermeasures to various...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer, for the provision of influenza virus vaccines. The contract has a ceiling value of $2,794,325.82 and a period of performance through November 15, 2016. Sanofi Pasteur Inc. has been awarded numerous indefinite delivery vehicles (IDVs) from various federal agencies, including a $5.87 billion IDIQ from the HHS Office of the Assistant Secretary for...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency to Sanofi Pasteur Inc. for the delivery of influenza virus vaccines. The award, valued at $55,978.87, is a firm fixed price delivery order contract with an ultimate completion date of April 19, 2024. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer of pharmaceuticals and medical goods that has previously received awards from various federal agencies to supply vaccines and...
The U.S. Department of Defense Medical Supply Chain has awarded a $1,153.52 firm fixed-price purchase order to Sanofi Pasteur Inc. for influenza virus vaccine. The award, issued on October 2, 2025, with an ultimate completion date of October 7, 2025, represents a small-value delivery order with no set-aside designation. Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer headquartered in Swiftwater, Pennsylvania, serves as the prime contractor and will fulfill this requirement directly. Sanofi Pasteur Inc. is a major supplier of vaccines and medical countermeasures to multiple federal agencies, including the Centers for Disease Control and Prevention, Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services. The company holds several high-value Indefinite Delivery Contracts with the CDC, including a $2.196 billion Vaccines for Children program contract and multiple influenza vaccine contracts ranging from $15 million to $47.5 million. This specific purchase order aligns with the Department of Defense's broader vaccination and immunization support programs, leveraging Sanofi Pasteur's established capacity to deliver vaccines rapidly to federal populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/2/25 |